Enanta Pharmaceuticals Inc
SWB:9EP
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Enanta Pharmaceuticals Inc
SWB:9EP
|
US |
|
C
|
Corvus Pharmaceuticals Inc
SWB:C17
|
US |
|
C
|
Constellation Software Inc
DUS:W9C
|
CA |
|
P
|
Primoris Services Corp
F:1PM
|
US |
|
E
|
Exide Industries Ltd
BSE:500086
|
IN |
|
Wheels India Ltd
BSE:590073
|
IN |
|
I
|
India Cements Capital Ltd
BSE:511355
|
IN |
|
Steppe Gold Ltd
OTC:STPGF
|
CA |
|
F
|
Futebol Clube do Porto Futebol Sad
SWB:FBC
|
PT |
|
H
|
Hipay Group SA
LSE:0RA7
|
FR |
|
SPAR Group Ltd
OTC:SGPPY
|
ZA |
|
Nichiden Corp
TSE:9902
|
JP |
|
Shenzhen Expressway Corp Ltd
F:SHZH
|
CN |
|
E
|
Elspec Engineering Ltd
TASE:ELSPC
|
IL |
|
Alkali Metals Ltd
BSE:533029
|
IN |
|
Mr DIY Group (M) Bhd
OTC:MDIYF
|
MY |
|
P
|
Pampa Energia SA
F:9PAA
|
AR |
Bankruptcy Probability
Enanta Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Enanta Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Enanta Pharmaceuticals Inc
NASDAQ:ENTA
|
339m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
504.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
237.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
193.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
83.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
79.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
88.4B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
48.8B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
40.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Enanta Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Enanta Pharmaceuticals Inc has total debt of 89.6m USD. This includes both short-term (0 USD) and long-term (89.6m USD) debt.
You can find a full breakdown on its Balance Sheet.